Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial.

Vera HimmelsbachMatthias JeschkeChristian M LangeBernhard Scheiner Matthias Pinter Friedrich Sinner Marino VeneritoAlexander QueckJörg TrojanOliver WaidmannFabian Finkelmeier

Published in: Cancers (2024)

Since history of liver transplantation is considered a contraindication for immunotherapy, prognosis of patients with HCC recurrence after LT remains poor.

Keyphrases

clinical trial
study protocol
phase iii
phase ii
randomized controlled trial